Board Meetings for KILITCH
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| KILITCH | Kilitch Drugs (India) Limited | 25 May 2018 | Financial Results | To consider and approve the financial results for the period ended March 31, 2018 | |
| KILITCH | Kilitch Drugs (India) Limited | 25 May 2018 | Dividend | In furtherance to our letter dated 17th May, 2018, we wish to inform you that Board of Directors may consider declaration/recommendation of Dividend at their meeting scheduled to be held on Friday, the 25thday of May, 2018, at its corporate office at 37, Ujagar Industrial Estate, W.T. Patil Marg, Deonar, Mumbai- 400 088, Maharashtra, India. | |
| KILITCH | Kilitch Drugs (India) Limited | 29 Mar 2018 | Other business matters | To consider other business matters relating to the conversion of 5,00,000 Warrants issued at a price of Rs. 59/- per warrant and allotment of 5,00,000 Equity shares of face value of Rs. 10/- each pursuant to such conversion of Warrants. | |
| KILITCH | Kilitch Drugs (India) Limited | 16 Mar 2018 | Other business matters | To consider appointment of Additional Director | |
| KILITCH | Kilitch Drugs (India) Limited | 14 Feb 2018 | Results/Others | Inter alia, 1. To consider and approve the unaudited financial results of the Company for the quarter ended December 31, 2017. 2. To consider appointment of Company Secretary & Compliance Officer of the Company. 3. To take note of outgoing Company secretary of the Company. 4. Any other matter with the permission of the chair. | |
| KILITCH | Kilitch Drugs (India) Limited | 14 Nov 2017 | Results | Inter alia, to consider and approve the un-audited financial results of the company for the quarter and half year ended September 30, 2017. | |
| KILITCH | Kilitch Drugs (India) Limited | 20 Sept 2017 | Others | To consider the items as specified in the agenda. | |
| KILITCH | Kilitch Drugs (India) Limited | 23 Aug 2017 | Meeting Updates | 1)To consider, adopt and approve the Notice of the 25th Annual General Meeting along with all relevant annexure for financial year 2016-2017;2) To finalize the dates of Book Closure for the purpose of forthcoming Annual General Meeting;3) To finalize the date, venue and time for convening Annual General Meeting of the Members of the Company;4) To consider reappointment of the Whole time Director of the Company;5) To consider revision in the remuneration of the Whole time Director of the Company;6) To consider amendment in the existing ESOP policy of the Company;7) To consider appointment of Statutory Auditors of the Company;8) Any other matter with the permission of the Chair. | |
| KILITCH | Kilitch Drugs (India) Limited | 14 Aug 2017 | Results/Others | (1)To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2017 along with the Limited Review Report; (2) To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2016-2017; (3) To finalize the dates of Book Closure for the purpose of forthcoming Annual General Meeting; (4) To finalize the date, venue and time for convening Annual General Meeting of the Members of the Company; (5) To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the 25th Annual General Meeting; (6) Any other matter with the permission of the Chair. | |
| KILITCH | Kilitch Drugs (India) Limited | 25 Jul 2017 | Results/Others | To consider various options to raise funds, including issue of Equity shares / Warrants on preferential basis, pursuant to applicable provisions of the Companies Act, 2013 along with applicable SEBI (LODR) Regulations, 2015, SEBI (ICDR) Regulations, 2009, as updated from time to time. To consider conducting postal ballot of the Company with respect to the above referred matter pursuant to applicable provisions of the Companies Act, 2013. Any other matter with the permission of the Chair. | |
| KILITCH | Kilitch Drugs (India) Limited | 30 May 2017 | Results/Others | To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2017; Any other matter with the permission of the Chair. Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company for the year ended March 31, 2017 from May 10, 2017 to June 01, 2017. | |
| KILITCH | Kilitch Drugs (India) Limited | 13 Feb 2017 | Results/Others | inter alia, to consider and take on record the following matters. 1. Unaudited (Provisional) Financial Result for the quarter ended December 31, 2016 along with the Limited Review Report as submitted by the Statutory Auditors of the Company. 2. Any other matter with the permission of Chair. Closure of Trading window The Company will close the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 on February 2, 2017 and the trading window will open on February 16, 2017. | |
| KILITCH | Kilitch Drugs (India) Limited | 14 Nov 2016 | Results | inter alia, to consider and take on record the following matters. 1. Unaudited (Provisional) Financial Result for the quarter and half year ended September 30, 2016 along with the Limited Review Report as submitted by the Statutory Auditors of the Company. 2. Any other matter with the permission of Chair. - Closure of Trading window The Company will close the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 on November 4, 2016 and the trading window will open on November 16, 2016. | |
| KILITCH | Kilitch Drugs (India) Limited | 12 Aug 2016 | Results/Others | 1. To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2016 along with the Limited Review Report; 2. To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2015-2016; 3. To finalize the dates of Book Closure for the purpose of forthcoming Annual General Meeting; 4.To finalize the date, venue and time for convening 24th Annual General Meeting of the Members of the Company; 5. To consider appointment of Scrutinizer to oversee the e-voting process of the Company at the Annual General Meeting; 6. Any other matter with the permission of the Chair. | |
| KILITCH | Kilitch Drugs (India) Limited | 30 May 2016 | Results/Others | (1) To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended March 31, 2016; (2) Any other matter with the permission of the Chair. |